Literature DB >> 3491138

Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound.

R D Camp, N J Fincham, F M Cunningham, M W Greaves, J Morris, A Chu.   

Abstract

The presence of neutrophil chemoattractant material in aqueous extracts of lesional psoriatic scale has been investigated by use of an agarose microdroplet chemokinesis method in combination with ultrafiltration and high-performance liquid chromatography (HPLC). Fractions were also assayed for murine thymocyte co-stimulating activity. Aqueous extracts of psoriatic scale contained significantly greater neutrophil chemokinetic activity than extracts of scale from normal skin. Successive ultrafiltration of extracts showed that the chemokinetic material was 10 to 30 kd. Heat lability and gel filtration HPLC characteristics suggested that the major chemokinetically active material in aqueous extracts of psoriatic scale is different from C5a des arg. Reversed-phase HPLC of 0.1% trifluoroacetic acid/acetonitrile extracts of psoriatic scale revealed two clearly resolved peaks of chemokinetic activity, the major peak consistently containing thymocyte co-stimulating activity. No significant neutrophil chemokinetic activity was seen in fractions after reversed-phase HPLC of scale from normal skin. These findings suggest that a major portion of the neutrophil chemoattractant activity in aqueous extracts of psoriatic scale is due to interleukin 1-like material, which may play a role in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491138

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  The new dermatology.

Authors:  M W Greaves
Journal:  BMJ       Date:  1990-02-17

2.  Elevated expression of NLRP1 and IPAF are related to oral pemphigus vulgaris pathogenesis.

Authors:  Reza Mahvelati Shamsabadi; Soroush Basafa; Reza Yarahmadi; Samaneh Goorani; Masood Khani; Maryam Kamarehei; Amir Hossein Kiani
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

3.  Effects of psoriatic scale extracts on oxidative metabolic responses in granulocytes assessed by chemiluminescence.

Authors:  T Kato; T Terui; H Takematsu; H Tagami
Journal:  Inflammation       Date:  1989-02       Impact factor: 4.092

4.  Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids.

Authors:  R D Camp; F M Cunningham; N J Fincham; M W Greaves; A Kobza Black; A I Mallet; P M Woollard
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

5.  Neutrophil stimulation by recombinant cytokines and a factor produced by IL-1-treated human synovial cell cultures.

Authors:  M L Watson; G P Lewis; J Westwick
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

6.  Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes.

Authors:  J N Barker; M L Jones; R S Mitra; E Crockett-Torabe; J C Fantone; S L Kunkel; J S Warren; V M Dixit; B J Nickoloff
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

7.  Demonstration of neutrophil chemotactic anaphylatoxins in human dandruff.

Authors:  T Kikuchi; I Horii; T Sakamoto; Y Nakayama; H Tagami
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

8.  EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner.

Authors:  Andrew Johnston; Johann E Gudjonsson; Abhishek Aphale; Andrew M Guzman; Stefan W Stoll; James T Elder
Journal:  J Invest Dermatol       Date:  2010-10-21       Impact factor: 8.551

9.  Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro.

Authors:  K Fogh; C G Larsen; L Iversen; K Kragballe
Journal:  Agents Actions       Date:  1992-03

10.  Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  K B Bacon; R D Camp; F M Cunningham; P M Woollard
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.